BioSpace News Archive

Mainstay Medical Holdings plc, announced that ReActiv8, its implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, has been approved for inclusion in the Prostheses List of reimbursed products in Australia, effective as of 1 July 2020.

Study meets primary endpoint demonstrating non-inferiority of roxadustat to darbepoetin in correction and maintenance of hemoglobin levels

Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Centogene N.V. announced that it will issue a press release reporting its financial results for the three months ended March 31, 2020 on Monday, June 15, 2020, and will host a conference call to discuss these results at 8 a.m. EST that day.

Boston Scientific announced that the Centers for Medicare & Medicaid Services has approved its application for a transitional pass-through payment category to describe single-use endoscopes, including the EXALT™ Model D Single-Use Duodenoscope, under the Medicare hospital outpatient prospective payment system.

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced a newly published study in Psychiatry Research.

Affinia Therapeutics, an innovative gene therapy company with a platform for rationally designed adeno-associated virus vectors and gene therapies, announced the appointment of Elliott Sigal, M.D., Ph.D., to the company’s Board of Directors.

Arch Biopartners Inc. announced it has submitted an Investigational New Drug Application to the U.S. Food and Drug Administration for its lead drug Metablok to conduct a Phase II trial to prevent acute organ inflammation and injury experienced by patients with COVID-19.

Bio-Techne Corporation announced the release of GMP ProDots™ Proteins to support cell and gene therapy manufacturing workflows.

Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), an online provider of healthcare information, professional training and educational services to healthcare professionals and the public in China , announced today that it has engaged with WentzMiller Global Services LLC (“WentzMiller”) to assist its efforts in distributing self-m